BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14583943)

  • 1. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Agra Y; Pelayo M; Sacristan M; Sacristán A; Serra C; Bonfill X
    Cochrane Database Syst Rev; 2003; (4):CD001990. PubMed ID: 14583943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001990. PubMed ID: 24282143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Pelayo Alvarez M; Gallego Rubio O; Bonfill Cosp X; Agra Varela Y
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001990. PubMed ID: 19821287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line chemotherapy for non-small cell lung cancer.
    Bonfill X; Serra C; Sacristán M; Nogué M; Losa F; Montesinos J
    Cochrane Database Syst Rev; 2002; (2):CD002804. PubMed ID: 12076452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
    Amarasena IU; Chatterjee S; Walters JA; Wood-Baker R; Fong KM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006849. PubMed ID: 26233609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
    Amarasena IU; Walters JA; Wood-Baker R; Fong K
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006849. PubMed ID: 18843733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
    Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
    Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction.
    Homs MY; v d Gaast A; Siersema PD; Steyerberg EW; Kuipers EJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004063. PubMed ID: 17054195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
    Cheng S; Evans WK; Stys-Norman D; Shepherd FA;
    J Thorac Oncol; 2007 Apr; 2(4):348-54. PubMed ID: 17409809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for hormone-refractory prostate cancer.
    Shelley M; Harrison C; Coles B; Staffurth J; Wilt TJ; Mason MD
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005247. PubMed ID: 17054249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for brain metastases from small cell lung cancer.
    Reveiz L; Rueda JR; Cardona AF
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007464. PubMed ID: 22696370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
    Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of ifosfamide in small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):59-67. PubMed ID: 1329214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study].
    Kokron O; Micksche M; Titscher R; Wrba H
    Onkologie; 1982 Apr; 5(2):56-9. PubMed ID: 6285241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.